Search results

  1. InitialConditions

    Trial Report Remotely delivered weight management for people with long COVID and overweight: the randomized wait-list-controlled ReDIRECT trial, 2025, Combet et al

    "people with overweight" Is that a new thing? Bizarrely, I first saw this usage only this morning in the title of this article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00355-1/fulltext
  2. InitialConditions

    Cerebrospinal fluid metabolomics, lipidomics and serine pathway dysfunction in [ME/CFS], 2025, Baraniuk

    Scientific Reports, despite being published by Nature [Publishing Group], is not a quality journal, but this fact isn't really appreciated outside of academia. They accept a large percentage of submitted papers, very often publish trash, and the journal has been implicated in numerous scientific...
  3. InitialConditions

    Paul Garner on Long Covid and ME/CFS - BMJ articles and other media.

    I listened to her audiobook 'It's All In Your Head' last year. Truly awful, and read by someone with the most snooty, patronising tone, which really fit the content. I could not finish it. More here: https://me-pedia.org/wiki/Suzanne_O'Sullivan
  4. InitialConditions

    Curing Cancer with Low Dose Naltrexone

    It's all very bizzare. LDN seems to have a cult following, much like ivermectin has. I think the LDN Trust puts out questionable literature to entice patients.
  5. InitialConditions

    [BBC News] 'My cold fingers were caused by a disease' - Article on Raynauds and scleroderma

    I developed Raynauds in my late teens or early 20s. I'm not sure I even have it any more as I don't go outside much, especially when it's cold. It never bothered me too much, but it seems to be indicative of some sort of underlying dysfunction that's likely auto-immune in nature.
  6. InitialConditions

    [BBC News] 'My cold fingers were caused by a disease' - Article on Raynauds and scleroderma

    https://www.bbc.co.uk/news/articles/cx2gky52p5qo "About 15 years ago, Tim Holt-Wilson noticed a "gradual degeneration" in the warmth of his fingers. The 66-year-old, who lives near Eye, in Suffolk, had already been diagnosed with the autoimmune condition Scleroderma - which caused stiff skin...
  7. InitialConditions

    Has anyone else here struggled with a persistent verruca?

    I love a story with a happy ending.
  8. InitialConditions

    BACME position paper on the management of ME/CFS, 2020, updated 2022 - discussion thread

    I didn't. At the time I was part of the CMRC PAG and some of these thoughts made it back to BACME members via feedback we were asked to give on a talk Vikki McKeever and Peter Gladwell gave. Also, Sue Pemberton, who had by then left BACME, messaged me on the subject of my blog, so it made it to...
  9. InitialConditions

    BACME position paper on the management of ME/CFS, 2020, updated 2022 - discussion thread

    I will share again my blog on this Position Paper: https://domsalisbury.github.io/mecfs/bacme_dysregulation/ I did try to be nice.
  10. InitialConditions

    UK Invest in ME conference 2025

    I think any conference would have more value if different orgs collaborated, but unfortunately they all seem to want to do their own thing.
  11. InitialConditions

    UK Invest in ME conference 2025

    They are calling it 'International Conference Week' now as there are several events/conferences running consecutively, as is usual for IIMER. More details here: https://www.investinme.org/meconferenceweek2025.shtml
  12. InitialConditions

    Review Defining and measuring long COVID fatigue: a scoping review 2024 Thomas et al

    Thanks for posting this Andy. These corrections have been made after I contacted the journal editors about the issues as well as Reviewer 1's 'I clearly didn't even bother to read the paper' review. BMJ tells me that "[they] have verified that the standard of peer review met the journal's...
  13. InitialConditions

    Open ReMEdi clinical trial, UK [Lindus Health, Alfred E. Tiefenbacher GmbH]

    I think we can safely conclude that it seems they don't want patients to know which drug this is, but they are probably underestimating our ability to figure it out (I think Amifampridine is a good guess).
Back
Top Bottom